The Team

BioCurate’s team brings decades of global experience, scientific and commercial expertise and proven success spanning therapeutic discovery, preclinical, clinical, regulatory and commercial areas. This expertise, together with a passion and commitment to create impact through translating discoveries into drugs, enables the team to recognise and realise real-world impact.

More than 170 years of combined biotech/pharma industry experience

Directly involved in over 13 Investigational New Drug applications (INDs)

Responsible for 30 therapeutics currently in the clinic

Directly involved in deals worth a cumulative total of more than $2.4 billion

Dr Damien Bates
Chief Executive Officer
Dr Damien Bates is a seasoned biopharma executive who has managed global teams across all phases of the product development lifecycle.

Read full profile
Linda Peterson
Chief Operating Officer & Company Secretary
Linda Peterson is the COO and Company Secretary for BioCurate Pty Ltd, responsible for leading and managing all aspects of the set-up and independent operations and governance of the company.

Read full profile
Dr Catherine Drinkwater
Director of Project Management
Dr Cathy Drinkwater has extensive experience in both academic research and industry drug development.

Read full profile
Dr Eric Hayes
Director of Partnerships
Dr Eric Hayes has academic, commercial drug development and pharmaceutical R&D support services experience, spanning over 25 years, in Europe, North America, Asia and Australia.

Read full profile
Dr Christopher Chan
Director of Protein Therapeutics
Dr Christopher Chan is an immunologist with expertise in therapeutic antibody development, immuno-oncology, inflammation, innate myeloid and lymphocyte biology, and T cell biology.

Read full profile
Dr Tifelle Reisinger
Program Manager
Dr Tifelle Reisinger is a medicinal chemist with 9 years drug discovery experience in the pharmaceutical and CRO industries in France, UK and Australia.

Read full profile
Dr Andy Allen
Associate Director of Project Management
Dr Andy Allen has academic, small biotech, and large pharmaceutical company experience spanning over 20 years, in both the UK and Australia.

Read full profile
Dr Belinda Huff
Associate Director of Small Molecule Therapeutics
Dr Belinda Huff is a medicinal chemist with 8 years drug discovery experience in the pharmaceutical industry.

Read full profile
Dr Heique Bogdawa
Project Manager
Dr Heique Bogdawa is a biochemist with 12 years protein engineering experience in the development of high-quality biologics to assist with the identification of hit candidates and their validation through pre-clinical studies.

Read full profile
Dr Jaclyn Sceneay
Senior Scientist, Pre-Clinical Biology
Dr Jaclyn Sceneay is an immuno-oncologist with experience in small molecule and PROTAC drug discovery, and microbiome therapeutics.

Read full profile
Francis Kirby
Business Analyst
Francis Kirby has project management experience in the academic and corporate sector together with a research background in the fields of Neuroscience and Immunology.

Read full profile
Michele Neisemann
Office Operations Manager
Michele Neisemann has extensive experience in executive administration, human resources, operations, and project management in the R&D sector.

Read full profile

Board of Directors

BioCurate is operationally independent and has an independent Board Chair, the Hon John Brumby, AO. Our Board of Directors has expertise in innovation, biotechnology, commercialisation, investment and corporate governance.

Discover more


Our Shareholders

Melbourne is home to two outstanding universities, Monash University and the University of Melbourne. Joining these two powerhouses to support the collaborative joint venture BioCurate, is the Victorian State Government, the nation’s largest investor in the life sciences.

Discover more



BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.

Discover more